Skip to main content
AMINOLOGICS CO.,LTD. logo

AMINOLOGICS CO.,LTD. - Investor Relations & Filings

Listed IPO Jun 2004
Ticker · 074430 ISIN · KR7074430000 KO Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2026-07-13 Major Shareholding Noti…
Country KR South Korea
Listing KO 074430 · 1 venue

About AMINOLOGICS CO.,LTD.

https://aminologics.co.kr/eng/main/

AMINOLOGICS CO.,LTD. is a specialty manufacturer of amino acids and their derivatives. The company's core competency is its proprietary chiral resolution platform technology, ARCA (Alanine Racemase Chiral). This innovative enzymatic process enables the cost-effective production of a wide range of high-purity chiral amino acids. These products serve as essential building blocks and Active Pharmaceutical Ingredients (APIs) for various sectors, including the pharmaceutical, fine chemical, agrochemical, and life science industries. The technology allows for the development of new products and treatments by providing materials with high optical purity at a reduced cost.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의대량보유상황보고서(일반)' which translates to 'Report on Large Shareholding of Stocks, etc. (General)'. This is a standard regulatory filing in South Korea (often referred to as a 5% report) used to disclose significant changes in share ownership by major shareholders or related parties. It contains detailed tables regarding shareholding percentages, acquisition methods (e.g., convertible bonds, market purchases), and the purpose of holding (management influence). It does not fit into financial report categories like 10-K or IR, nor is it a simple announcement (RPA). It is a specific regulatory disclosure of major shareholding status.
2026-07-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주특정증권등소유상황보고서', which translates to 'Report on Ownership of Specific Securities by Executives and Major Shareholders'. This is a standard regulatory filing in South Korea (often referred to as a 'Large Shareholding Report' or 'Insider Ownership Report') used to disclose changes in shareholdings by major shareholders or executives. Since the document details the acquisition of shares and convertible bonds by a major shareholder (Samoh Pharm) in AminoLogics, it falls under the category of Major Shareholding Notification (MRQ).
2026-07-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-07-10 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 99% confidence The document is titled '분기보고서' covering the period January 1, 2026 to March 31, 2026 and includes detailed financial statements, segment information, business overview, and actual quarterly performance metrics. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the official results of the company’s Annual General Meeting (정기주주총회결과) held on 2026-03-31, detailing each resolution item, vote counts, approval status, and director election outcomes. This aligns with the category for Declaration of Voting Results & Voting Rights Announcements.
2026-03-31 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 29th fiscal year (2025) of Aminologics Co., Ltd. It contains comprehensive information including company overview, business activities, financial data, and management details. In the context of Korean corporate filings, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report, as it is the primary annual disclosure document filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2025
2026-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.